Loading...

PE anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
a-30-F11_PE_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE
  • a-30-F11_PE_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE
  • b-30-F11_PE_CD45_Antibody_2_041922
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103105 50 µg 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103106 200 µg 69€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  2. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  3. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  4. Vercauteren Drubbel A, et al. 2021. Cell Stem Cell. . PubMed
  5. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  6. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  7. Hepler C et al. 2017. eLife. 6 pii: e27669. PubMed
  8. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  9. Khorooshi R, et al. 2020. Acta Neuropathol Commun. 8:02. PubMed
  10. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  11. Linden J, et al. 2020. J Interferon Cytokine Res. 40:292. PubMed
  12. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  13. Friesen M, et al. 2022. Brain Pathol. 32:e13032. PubMed
  14. Kang H, et al. 2022. Adv Mater. 34:e2106500. PubMed
  15. Brandt KJ, et al. 2022. Int J Mol Sci. 23: . PubMed
  16. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  17. Cox MJ, et al. 2022. Leukemia. 36:1635. PubMed
  18. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  19. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  20. Liu X, et al. 2022. Chin Med J (Engl). 135:1821. PubMed
  21. Zhang X, et al. 2022. EBioMedicine. 84:104275. PubMed
  22. Dedousis N, et al. 2022. J Lipid Res. 63:100284. PubMed
  23. Yang J, et al. 2022. Mol Ther Nucleic Acids. 30:184. PubMed
  24. Hirano K, et al. 2023. Life Sci Alliance. 6: . PubMed
  25. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  26. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  27. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  28. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  29. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  30. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  31. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  32. Wang R, et al. 2023. iScience. 26:105954. PubMed
  33. Vuerich R, et al. 2023. NPJ Regen Med. 8:8. PubMed
  34. Tan Y, et al. 2023. NPJ Regen Med. 8:7. PubMed
  35. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  36. Masuda H, et al. 2022. MAbs. 14:2122275. PubMed
  37. Shi H, et al. 2022. Nutrients. 14:. PubMed
  38. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  39. Elbasiony E, et al. 2023. NPJ Aging. 9:2. PubMed
  40. Pioli KT, et al. 2023. iScience. 26:106223. PubMed
  41. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  42. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  43. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  44. Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed
  45. Sun D, et al. 2021. Cell Stem Cell. . PubMed
  46. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  47. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  48. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  49. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  50. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  51. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  52. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  53. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  54. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  55. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  56. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  57. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  58. Cieslik KA, et al. 2018. J Gerontol A Biol Sci Med Sci. 73:1167. PubMed
  59. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  60. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  61. Chen J, et al. 2021. Sci Adv. 7:. PubMed
  62. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  63. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  64. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  65. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  66. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  67. Shmeleva EV, et al. 2019. Front Immunol. 10:1780. PubMed
  68. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  69. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  70. Catrina AM, et al. 2021. Rom J Morphol Embryol. 62:109. PubMed
  71. Aoki H, et al. 2009. Development. 136:2511. PubMed
  72. Guha S, et al. 2014. Brain Behav Immun. 11:123. PubMed
  73. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  74. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  75. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  76. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  77. Wang Y, et al. 2021. Nat Commun. 12:2343. PubMed
  78. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  79. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  80. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  81. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  82. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  83. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  84. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  85. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  86. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  87. Serrano Martinez P, et al. 2022. iScience. 25:105047. PubMed
  88. Ogawa-Wong A, et al. 2022. Metabolites. 12:. PubMed
  89. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  90. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  91. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  92. Fontana D, et al. 2020. Hemasphere. e497:4. PubMed
  93. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  94. Green DP, et al. 2019. Neuron. 101:412. PubMed
  95. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  96. An J, et al. 2022. iScience. 25:103570. PubMed
  97. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  98. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  99. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  100. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  101. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  102. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  103. Yang Z, et al. 2020. Sci Rep. 17757:10. PubMed
  104. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  105. Sardella C, et al. 2018. J Invest Dermatol. 138:500. PubMed
  106. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  107. Oliver J, et al. 2009. J Am Soc Nephrol. 2.440972222. PubMed
  108. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  109. Chang CS, et al. 2022. iScience. 25:103738. PubMed
  110. Sinha VC, et al. 2021. Nat Commun. 12:5024. PubMed
  111. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  112. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  113. Slezak AJ, et al. 2022. ACS Cent Sci. 8:1435. PubMed
  114. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  115. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  116. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  117. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  118. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  119. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  120. Ebrahimi-Nik H, et al. 2021. Nat Commun. 12:6423. PubMed
  121. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  122. Barker KA, et al. 2021. Journal of Clinical Investigation. 131(11):. PubMed
  123. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  124. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  125. Ito T, et al. 2021. Commun Biol. 4:694. PubMed
  126. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  127. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  128. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  129. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  130. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  131. Wang QA et al. 2018. Cell metabolism. 28(2):282-288 . PubMed
  132. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  133. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  134. Douam F, et al. 2017. Mbio. 10.1128/mBio.00819-17. PubMed
  135. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  136. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  137. Wijewarnasuriya D, et al. 2020. Cancer Immunol Res. 0.841666667. PubMed
  138. Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed
  139. Meng X, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  140. Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed
  141. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  142. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  143. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  144. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  145. McCallion A, et al. 2022. Front Immunol. 13:961599. PubMed
  146. Matsumoto A, et al. 2021. iScience. 24:102839. PubMed
  147. Lee-Chang C, et al. 2021. J Exp Med. 218:. PubMed
  148. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  149. Senthil K, et al. 2021. Invest Ophthalmol Vis Sci. 62:38. PubMed
  150. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  151. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  152. Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed
  153. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  154. Kronborg Hansen AK, et al. 2022. Int J Mol Sci. 23:. PubMed
  155. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  156. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  157. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  158. Liu B, et al. 2013. Development. 140:780. PubMed
  159. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  160. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  161. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  162. Liu X, et al. 2021. Int J Med Sci. 18:3125. PubMed
  163. Song E, et al. 2020. Nature. 577:689. PubMed
  164. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  165. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  166. Milon B, et al. 2021. Cell Rep. 36:109758. PubMed
  167. Dieu RS, et al. 2021. Front Neurosci. 15:685645. PubMed
  168. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  169. Korin B, et al. 2020. Sleep. :43. PubMed
  170. An X, et al. 2020. Thyroid. . PubMed
  171. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  172. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  173. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  174. Sanz-Ros J, et al. 2022. Sci Adv. 8:eabq2226. PubMed
  175. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  176. Bollinger JL, et al. 2020. Neuropsychopharmacology. 45:1766. PubMed
  177. Yue F, et al. 2022. Cell Rep. 38:110267. PubMed
  178. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  179. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  180. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  181. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  182. Singh K, et al. 2021. Front Immunol. 640837:12. PubMed
  183. Wen G, et al. 2018. J Am Heart Assoc. 7:e008187. PubMed
  184. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  185. Orhon I, et al. 2021. Autophagy. :1. PubMed
  186. Szõke D, et al. 2021. Nat Commun. 12:3460. PubMed
  187. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  188. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  189. Gawish R, et al. 2022. Elife. 11:. PubMed
  190. Li J, et al. 2021. eLife. 10:00. PubMed
  191. Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed
  192. Engelmann R, et al. 2017. J Negat Results Biomed. 16:05. PubMed
  193. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  194. Lehmann ML, et al. 2018. Sci Rep. 8:11240. PubMed
  195. Lehmann M, et al. 2020. Cell Signal. 70:109588. PubMed
  196. Cugurra A, et al. 2021. Science. 373:. PubMed
  197. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  198. Lupan AM, et al. 2021. Aging (Albany NY). 13:15875. PubMed
RRID
AB_312970 (BioLegend Cat. No. 103105)
AB_312971 (BioLegend Cat. No. 103106)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD45 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account